Document is current
Any future updates will be listed below
-
Authors
Berkane, Yanis
Filz von Reiterdank, Irina
Tawa, Pierre
Charlès, Laura
Goutard, Marion
Dinicu, Antonia T.
Toner, Mehmet
Bertheuil, Nicolas
Mink van der Molen, Aebele B.
Coert, J. Henk
Lellouch, Alexandre G.
Randolph, Mark A.
Cetrulo, Curtis L. Jr.
Uygun, Korkut
-
Funding
Funding for this research was provided by:
Shriners Hospitals for Children (85105-BOS-23, 84308-BOS-22)
Centre Hospitalier Universitaire de Rennes (Prix mobilité 2021)
Université de Rennes 1
Fondation des Gueules Cassées (09-2022)
National Science Foundation (EEC 1941543)
U.S. Army Medical Research Acquisition Activity (W81XWH-17-1-0437, W81XWH-17-1-0440)
National Institute for Health Care Management Foundation (R01EB028782, R56AI171958)
- License Information
-
More Information
Article History
Received: 3 October 2023
Accepted: 23 May 2024
First Online: 1 June 2024
Competing interests
: K.U., C.L.C, A.G.L., M.T and Y.B. have patent applications relevant to this field. K.U. and M.T. have financial interests in and serve on the Scientific Advisory Board for Sylvatica Biotech Inc., a private company developing high subzero organ preservation technologies. Competing interests for Massachusetts General Hospital investigators are managed by the MGH and MGB in accordance with their conflict-of-interest policies.
